|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.34 | 89.43 | 104.26 | 0.53 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pesticides & Agrochemicals
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
4095.95
|
|
|
52-Week-Low (Rs.)
|
2289.60
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Operational & Financial Ratios | | | | | | Earnings Per Share (Rs) | 93.07 | 137.41 | 127.65 | 5.28 | 18.88 | CEPS(Rs) | 135.13 | 176.81 | 167.83 | 47.06 | 52.86 | DPS(Rs) | 8.00 | 6.00 | 10.00 | 3.00 | 5.00 | Book NAV/Share(Rs) | 622.72 | 538.59 | 411.59 | 286.62 | 325.79 | Tax Rate(%) | 25.86 | 21.72 | 34.21 | -131.01 | -13.72 | Margin Ratios | | | | | | Core EBITDA Margin(%) | 4.90 | 6.78 | 6.42 | 3.66 | 2.48 | EBIT Margin(%) | 3.98 | 5.80 | 9.03 | 1.97 | 3.94 | Pre Tax Margin(%) | 3.88 | 5.66 | 8.54 | 0.13 | 1.19 | PAT Margin (%) | 2.88 | 4.43 | 5.62 | 0.30 | 1.36 | Cash Profit Margin (%) | 4.18 | 5.70 | 7.39 | 2.68 | 3.80 | Performance Ratios | | | | | | ROA(%) | 6.21 | 10.18 | 10.94 | 0.54 | 2.13 | ROE(%) | 16.03 | 28.92 | 36.57 | 1.73 | 5.94 | ROCE(%) | 22.13 | 36.48 | 46.15 | 7.09 | 10.46 | Asset Turnover(x) | 2.16 | 2.30 | 1.95 | 1.78 | 1.57 | Sales/Fixed Asset(x) | 7.64 | 7.87 | 5.98 | 4.85 | 3.86 | Working Capital/Sales(x) | 7.99 | 10.08 | 11.49 | 34.28 | 11.17 | Efficiency Ratios | | | | | | Fixed Capital/Sales(x) | 0.13 | 0.13 | 0.17 | 0.21 | 0.26 | Receivable days | 64.76 | 63.58 | 64.60 | 59.16 | 64.49 | Inventory Days | 54.25 | 47.26 | 57.35 | 66.47 | 67.59 | Payable days | 107.31 | 101.49 | 115.41 | 104.69 | 103.50 | Valuation Parameters | | | | | | PER(x) | 24.49 | 22.45 | 16.24 | 212.80 | 78.07 | PCE(x) | 16.87 | 17.44 | 12.36 | 23.89 | 27.88 | Price/Book(x) | 3.66 | 5.73 | 5.04 | 3.92 | 4.52 | Yield(%) | 0.35 | 0.19 | 0.48 | 0.27 | 0.34 | EV/Net Sales(x) | 0.70 | 1.01 | 0.94 | 0.71 | 1.21 | EV/Core EBITDA(x) | 13.12 | 14.11 | 13.59 | 14.95 | 28.17 | EV/EBIT(x) | 17.04 | 16.96 | 10.09 | 36.20 | 30.66 | EV/CE(x) | 1.42 | 2.09 | 4.62 | 2.85 | 3.13 | M Cap / Sales | 0.72 | 1.02 | 0.94 | 0.64 | 1.06 | Growth Ratio | | | | | | Net Sales Growth(%) | 4.16 | 37.05 | 25.86 | 26.04 | 7.92 | Core EBITDA Growth(%) | -22.78 | 42.26 | 81.42 | 40.60 | -29.94 | EBIT Growth(%) | -28.52 | -12.13 | 491.57 | -36.81 | -36.53 | PAT Growth(%) | -32.27 | 7.64 | 2,316.31 | -72.01 | -66.85 | EPS Growth(%) | -32.27 | 7.64 | 2,316.31 | -72.01 | -66.85 | Financial Stability Ratios | | | | | | Total Debt/Equity(x) | 0.00 | 0.00 | 0.09 | 0.53 | 0.65 | Current Ratio(x) | 1.47 | 1.36 | 1.25 | 1.07 | 1.26 | Quick Ratio(x) | 0.87 | 0.83 | 0.80 | 0.59 | 0.68 | Interest Cover(x) | 40.07 | 39.52 | 18.75 | 1.07 | 1.43 | Total Debt/Mcap(x) | 0.00 | 0.00 | 0.02 | 0.14 | 0.14 |
|
|
|
|
|
|